Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

The Food and Drug Administration allows for licensed compounding pharmacies to make copies of certain drugs in short supply, and that has included semaglutide and tirzepatide, the main ingredients in ...